Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Aurora Cannabis ( (TSE:ACB) ) has provided an announcement.
Aurora Cannabis announced it will host a conference call to discuss its second quarter 2026 financial results on November 5, 2025. The call will be led by the company’s executive chairman and CEO, Miguel Martin, and CFO, Simona King. This announcement is part of Aurora’s ongoing efforts to maintain transparency with investors and stakeholders, reflecting its commitment to providing timely updates on its financial performance.
The most recent analyst rating on (TSE:ACB) stock is a Hold with a C$9.00 price target. To see the full list of analyst forecasts on Aurora Cannabis stock, see the TSE:ACB Stock Forecast page.
Spark’s Take on TSE:ACB Stock
According to Spark, TipRanks’ AI Analyst, TSE:ACB is a Neutral.
Aurora Cannabis’s overall score is driven by strong earnings call results, showcasing significant revenue growth and improved financial metrics. However, ongoing profitability challenges and a negative P/E ratio weigh heavily on the stock’s valuation and financial performance.
To see Spark’s full report on TSE:ACB stock, click here.
More about Aurora Cannabis
Aurora Cannabis is a leading global medical cannabis company based in Edmonton, Alberta, Canada. The company serves both medical and consumer markets across Canada, Europe, Australia, and New Zealand. Aurora is known for its diverse brand portfolio, which includes both adult-use and medical cannabis brands. The company is driven by science and innovation, focusing on high-quality cannabis products and has a controlling interest in Bevo Farms Ltd., a major supplier of propagated agricultural plants in North America.
Average Trading Volume: 807,305
Technical Sentiment Signal: Hold
Current Market Cap: C$422.8M
For a thorough assessment of ACB stock, go to TipRanks’ Stock Analysis page.